发明名称 |
COMPOSITION FOR NASAL ABSORPTION |
摘要 |
<p>It is intended to provide a composition for nasal administration which shows an extremely low expression ratio of side effects, quickly exerts an analgesic effect and has an excellent bioavailability, compared with preparations for oral administration. A composition for nasal absorption wherein an opiopid analgesic in an effective dose is uniformly dispersed in a carrier comprising calcium carbonate and/or calcium phosphate and having an average grain size of 500 mum or less and adhered/boded thereto.</p> |
申请公布号 |
WO2004006929(A1) |
申请公布日期 |
2004.01.22 |
申请号 |
WO2003JP08838 |
申请日期 |
2003.07.11 |
申请人 |
YANAGAWA, AKIRA;TAIHO PHARMACEUTICAL CO., LTD. |
发明人 |
YANAGAWA, AKIRA |
分类号 |
A61K9/16;A61K9/00;A61K31/485;A61K47/02;A61K47/04;A61P25/04;(IPC1-7):A61K31/485;A61K47/12;A61K9/72;A61K9/14 |
主分类号 |
A61K9/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|